Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endocrine modulators: risk characterization and assessment.

P A Fenner-Crisp1

  • 1Office of Pesticide Programs, US Environmental Protection Agency, Washington, DC 20460, USA. fenner-crisp.penelope@epa.gov

Toxicologic Pathology
|June 22, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

FQPA science issues: common mechanism of toxicity and cumulative risk assessment.

Regulatory toxicology and pharmacology : RTP·2000
Same author

Endocrine disruptor risk characterization: an EPA perspective.

Regulatory toxicology and pharmacology : RTP·1997
Same author

Regulatory implications: U.S. Environmental Protection Agency.

Annals of the New York Academy of Sciences·1996
Same author

Impact of the Delaney Clause in the EPA.

Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie·1996
Same author

Pesticides--the NAS report: how can the recommendations be implemented?

Environmental health perspectives·1995
Same author

Evaluation of the carcinogenic potential of pesticides. 4. Chloroalkylthiodicarboximide compounds with fungicidal activity.

Regulatory toxicology and pharmacology : RTP·1993
Same journal

Comparison of Standard Clinical Pathology Parameter Values in Fasted and Fed Rats and Non-human Primates.

Toxicologic pathology·2026
Same journal

Time-Dependent Autolysis in Ex Vivo-Maintained Rat Tissue in Saline: A Descriptive Study and Practical Guidance for Histopathologic Assessment.

Toxicologic pathology·2026
Same journal

New Approach Methodologies (NAMs) for Carcinogenicity Evaluation.

Toxicologic pathology·2026
Same journal

2025 International Academy of Toxicologic Pathology (IATP) Satellite Symposium: Pathology Working Groups (PWGs) in Toxicologic Pathology.

Toxicologic pathology·2026
Same journal

Toxicologic Pathology Forum*: Opportunities and Challenges in the Use of Artificial Intelligence in Nonclinical Toxicologic Histopathology Evaluations.

Toxicologic pathology·2026
Same journal

New Modalities and Carcinogenicity Assessment.

Toxicologic pathology·2026
See all related articles

Man-made chemicals, known as endocrine disruptors, may cause adverse effects in wildlife and humans, impacting reproduction and development. The US government employs risk assessment to manage these environmental endocrine modulators.

Area of Science:

  • Environmental toxicology
  • Endocrinology
  • Risk assessment

Background:

  • Growing evidence suggests man-made chemicals cause adverse effects in wildlife and humans.
  • These effects are often linked to interactions with hormone systems, impacting reproduction, development, and potentially increasing cancer risk.
  • Substances causing these effects are termed endocrine modulators or endocrine disruptors.

Purpose of the Study:

  • To address the scientific and regulatory debate surrounding endocrine disruptors.
  • To outline the US government's approach to risk assessment for endocrine disruptors.
  • To detail the US Environmental Protection Agency's current policies and practices.

Main Methods:

  • Review of accumulating scientific information on endocrine disruptors.

Related Experiment Videos

  • Analysis of regulatory approaches to chemical management.
  • Focus on risk assessment methodologies used by the US government.

    • Main Results:

    • Adverse effects on reproduction and development observed in wildlife and humans.
    • Potential links to cancers and immune system effects noted.
    • Significant scientific and regulatory debate exists regarding the scope of the problem.

    Conclusions:

    • Risk assessment is crucial for regulatory decisions on endocrine disruptors.
    • The US EPA utilizes specific practices and policies for evaluating these chemicals.
    • Further research and regulatory strategies are needed to address endocrine disruptors.